Prevalence of sarcopenia in elderly maintenance hemodialysis patients: The impact of different diagnostic criteria

Lamarca, Fernando; Carrero, Juan Jesús; Rodrigues, J. D. C.; Bigogno, Fernanda Guedes; Fetter, Renata; Avesani, Carla María

doi:10.1007/s12603-014-0455-y

Cited by 9 publications

(11 citation statements)

References 30 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…However, methodological differences also may be an important explanation, and a better understanding of the impact of methodology on observed prevalence is important to allow comparison across populations and to better address the potential association of sarcopenia with outcomes. To that end, Lamarca et al [44 ■■ ] set out to examine the differences in prevalence of sarcopenia introduced by varying the definitions employed. They assessed 102 Brazilian hemodialysis patients for sarcopenia using criteria for low muscle mass based on dual-energy X-ray absorptiometry (DXA), bioelectrical impedance analysis, skinfold thicknesses, and midarm muscle circumference [44 ■■ ].…”

Section: Introductionmentioning

confidence: 99%

“…To that end, Lamarca et al [44 ■■ ] set out to examine the differences in prevalence of sarcopenia introduced by varying the definitions employed. They assessed 102 Brazilian hemodialysis patients for sarcopenia using criteria for low muscle mass based on dual-energy X-ray absorptiometry (DXA), bioelectrical impedance analysis, skinfold thicknesses, and midarm muscle circumference [44 ■■ ]. Eighty-five percent of the patients were weak, and the prevalence of sarcopenia varied from 4 to 63%, depending on the method and cutoff limit used to designate muscle mass as low (Table 1).…”

Section: Introductionmentioning

confidence: 99%

See 1 more Smart Citation

Body composition in chronic kidney disease

Johansen¹,

Lee²

2015

Current Opinion in Nephrology and Hypertension

View full text Add to dashboard Cite

Purpose of review To summarize the latest information on body composition among patients with chronic kidney disease and its association with outcomes. Recent findings Obesity is increasing among patients with end-stage renal disease and is more prevalent when direct measures of adiposity are used rather than BMI. High BMI is not associated with better survival among patients with earlier chronic kidney disease or after kidney transplantation, suggesting that excess fat is most protective among the sickest patients. Despite the positive association between BMI and survival among patients with end-stage renal disease, visceral fat is associated with coronary artery calcification and adverse cardiovascular events. Muscle wasting is prominent among patients with chronic kidney disease, sometimes even in the setting of obesity. Obesity and muscle wasting are associated with worse physical functioning. Indicators of low muscle size and strength are associated with higher mortality. Some interventions can affect body composition, but whether they affect survival has not been determined. Summary Recent studies show that a high BMI is not protective for all patients with chronic kidney disease and is associated with poor physical functioning and frailty. Visceral adiposity is associated with adverse cardiovascular outcomes. Sarcopenia is common among patients with end-stage renal disease and is associated with worse physical performance and higher mortality.

show abstract

Section: Introductionmentioning

confidence: 99%

Section: Introductionmentioning

confidence: 99%

Body composition in chronic kidney disease

Johansen¹,

Lee²

2015

Current Opinion in Nephrology and Hypertension

View full text Add to dashboard Cite

show abstract

“…Differences in prevalence of loss of muscle mass according to lean body mass (LBM) index and appendicular LBM cutoffs according to European and North American clinical guidelines 13 . Names are cited for the first authors of studies that define cutoff points for sarcopenia 6 , 8 , 11 , 12 , 14 . BMI, body mass index.…”

Section: Resultsmentioning

confidence: 99%

“…The FNIH, the European Working Group on Sarcopenia in Older People, and NHANES 6 , 11 , 12 all used healthy elderly patients >60 years old. Our study group was marginally younger, with mean ages of 53 years (female) and 58 years (male).…”

Section: Discussionmentioning

confidence: 99%

Differences in Prevalence of Muscle Wasting in Patients Receiving Peritoneal Dialysis per Dual‐Energy X‐Ray Absorptiometry Due to Variation in Guideline Definitions of Sarcopenia

et al. 2017

View full text Add to dashboard Cite

We found that the prevalence varied markedly depending on the cutoff criteria used to define muscle wasting. Very few patients had sarcopenic obesity. The higher prevalence for males requires further study but was not associated with dialysis treatment. Our study highlights the need for agreed criteria to define pathologic muscle wasting from that which is age associated to allow for interventional screening programs.

show abstract

“…A cross-sectional data from National Health and Nutrition Examination Survey (NHANES) [86] demonstrated a higher prevalence of sarcopenia with lower estimated glomerular filtration rate suggesting that muscle wasting progresses as renal function deteriorates. Several studies have reported a prevalence of sarcopenia or low muscle mass, based on estimates of muscle mass indexed to body size and used thresholds for low muscle mass that were based on sex-specific norms, among patients with ESRD from 4 to 60% [87][88][89]. The broad range in the prevalence of sarcopenia is mainly due to the lack of consensus criteria on the definition of low muscle mass to allow comparison across populations.…”

Section: Magnitude Of Low Muscle Mass and Sarcopenia With Associated mentioning

confidence: 99%

Body Composition and Its Clinical Outcome in Maintenance Hemodialysis Patients

Kittiskulnam¹,

Eiam‐Ong²

2018

Aspects in Dialysis

View full text Add to dashboard Cite

Previous epidemiological cohorts demonstrated that higher body mass index (BMI) was associated with greater survival in patients treated by hemodialysis. Although BMI is a simple measure of adiposity in general population, it may be an inaccurate indicator of nutritional status, particularly among dialysis patients given that it does not differentiate between muscle mass and fat as well as body fat distribution. This problem might be aggravated in end-stage renal disease patients because of wasting or edema. In addition, individuals with higher BMI usually have both higher muscle and fat mass than those with lower BMI. Therefore, more sophisticated tool of body composition analysis is needed to address the query of which component is associated with mortality outcome among patients receiving hemodialysis. We summarized the current state of body composition, including lean and fat tissue evaluated by bioelectrical impedance analysis, dual X-ray absorptiometry, computerized tomography, or magnetic resonance imaging, and its association with clinical outcomes among hemodialysis patients. The studies using anthropometry for the estimation of muscle mass, either mid-arm muscle circumference as a proxy of muscle mass or skinfold thickness and waist circumference as a surrogate of body fat and visceral fat, respectively, were all included in this review.

show abstract

Prevalence of sarcopenia in elderly maintenance hemodialysis patients: The impact of different diagnostic criteria

Abstract: A wide prevalence of sarcopenia is observed depending on the method and cutoff limit applied. This may limit extrapolate on to clinical practice. BIA and SKF were the surrogate methods to assess muscle mass with the best concordance with DXA in elderly MHD patients.

Cited by 9 publications

References 30 publications

Body composition in chronic kidney disease

Body composition in chronic kidney disease

Differences in Prevalence of Muscle Wasting in Patients Receiving Peritoneal Dialysis per Dual‐Energy X‐Ray Absorptiometry Due to Variation in Guideline Definitions of Sarcopenia

Body Composition and Its Clinical Outcome in Maintenance Hemodialysis Patients

Contact Info

Product

Resources

About